Gornitzky represented ZOLL Medical Corporation, an Asahi Kasei company, that develops and markets medical devices and software solutions, in its acquisition by way of a reverse triangular merger of Itamar Medical Ltd., for approximately US $538 million. Itamar is a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders. Itamar was dually listed and its American Depositary Shares (ADSs) and ordinary shares were traded on Nasdaq and the Tel Aviv Stock Exchange, respectively.
ZOLL was represented by partners Chaim Friedland and Ari Fried, together with senior associates Nir Knoll, and associates Amit Ron, Desiree Reichman, Josh Kersner and Danielle Frenkel Breiner. They were supported by Partner Dr. Assaf Prussak and Senior Associate Nir Moses (Tax), Partner Avner Finkelshtein and associate Lior Frank (Antitrust), Partner Dr. Ziv Rotenberg and associate Anat Zehavi (IP), associates Lee Alter Kizis and Keren Ovadia (Employment), Partner Assaf Harel and associate Rebecca Genis (Data Protection and Privacy) and Partner Hila Shimon and associate May Galanti (Regulatory).
